Acutus Medical, Inc. (AFIB)
| Market Cap | 2.99K -99.9% |
| Revenue (ttm) | 20.16M +181.4% |
| Net Income | -9.55M |
| EPS | -0.32 |
| Shares Out | 29.91M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,336 |
| Open | 0.0001 |
| Previous Close | 0.0002 |
| Day's Range | 0.0001 - 0.0001 |
| 52-Week Range | 0.000001 - 0.0330 |
| Beta | 6.14 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 31, 2026 |
About Acutus Medical
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California. [Read more]
Financial Performance
In 2024, Acutus Medical's revenue was $20.16 million, an increase of 181.37% compared to the previous year's $7.16 million. Losses were -$9.55 million, -88.31% less than in 2023.
Financial StatementsNews
Acutus Medical Reports Full Year 2024 Financial Results
CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the full year of 2024.
Acutus Medical Annual report: Q4 2024
Acutus Medical has published its Q4 2024 annual report on March 24, 2025.
Acutus Medical Earnings release: Q4 2024
Acutus Medical released its Q4 2024 earnings on March 24, 2025, summarizing the period's financial results.
Acutus Medical announces downsizing, sees $1.4 M-$1.8M in charges
Acutus Medical (AFIB) announced a realignment of resources and operational downsizing. Dr. Shaden Marzouk, Chairperson of the Board of Directors of Acutus, commented, “Following an extensive strategic...
Acutus Medical Announces Operational Downsizing
CARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and operational downsizing.
Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results
CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the third quarter and year-to-date of 2024.
Acutus Medical Earnings release: Q3 2024
Acutus Medical released its Q3 2024 earnings on November 14, 2024, summarizing the period's financial results.
Acutus Medical Quarterly report: Q3 2024
Acutus Medical has published its Q3 2024 quarterly earnings report on November 14, 2024.
Acutus Medical Quarterly report: Q2 2024
Acutus Medical has published its Q2 2024 quarterly earnings report on August 9, 2024.
Acutus Medical Earnings release: Q2 2024
Acutus Medical released its Q2 2024 earnings on August 9, 2024, summarizing the period's financial results.
Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results
CARLSBAD, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the second quarter and year-to-date of 2024.
Acutus Medical Reports First Quarter 2024 Financial Results
CARLSBAD, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the first quarter of 2024.
Acutus Medical Quarterly report: Q1 2024
Acutus Medical has published its Q1 2024 quarterly earnings report on May 9, 2024.
Acutus Medical Earnings release: Q1 2024
Acutus Medical released its Q1 2024 earnings on May 9, 2024, summarizing the period's financial results.
Acutus Medical Proxy statement: Proxy Filing
Acutus Medical filed a proxy statement on April 25, 2024, providing details for shareholder voting and corporate governance matters.
Acutus Medical Proxy statement: Proxy Filing
Acutus Medical filed a proxy statement on April 25, 2024, providing details for shareholder voting and corporate governance matters.
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the fourth quarter and full year ended December 31,2023.
Acutus Medical Earnings release: Q4 2023
Acutus Medical released its Q4 2023 earnings on April 1, 2024, summarizing the period's financial results.
Acutus Medical Annual report: Q4 2023
Acutus Medical has published its Q4 2023 annual report on April 1, 2024.
Acutus Medical Quarterly report: Q3 2023
Acutus Medical has published its Q3 2023 quarterly earnings report on November 13, 2023.
Acutus Medical Earnings release: Q3 2023
Acutus Medical released its Q3 2023 earnings on November 13, 2023, summarizing the period's financial results.
Acutus Medical to Cancel Third Quarter 2023 Conference Call
CARLSBAD, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced that, following the Company's announcement of its strategic realign...
Acutus Medical announces financial impact of corporate restructuring
Going forward, the company’s exclusive sources of revenue will come from the sale of left-heart access products at transfer prices specified in Acutus’ existing distribution agreement with Medtronic a...
Acutus Medical to reduce workforce by 65% in corporate restructuring
Acutus Medical (AFIB) announced a realignment of resources and corporate restructuring. The company is implementing a shift in its business model to solely support the manufacturing and distribution o...
